Loss of CFTR results in reduction of histone deacetylase 2 in airway epithelial cells.

Inflammatory cytokines, particularly the neutrophil chemoattractant IL-8, are elevated in the cystic fibrosis (CF) airway, even in the absence of detectable infection. The transcriptional regulation of many inflammatory genes, including IL8 (CXCL8), involves chromatin remodeling through histone acetylation. NF-kappaB is known to facilitate histone acetylation of IL8 and other proinflammatory gene promoters, but we find that increased NF-kappaB activation cannot explain the elevated IL8 expression and promoter acetylation seen in CFTR-deficient cells. Recognized components of the NF-kappaB-coactivator complex, acetyltransferase CBP, p300, and the histone deacetylase HDAC1, are unchanged by CFTR activity. However, we find that the histone acetyltransferase (HAT)/HDAC balance is sensitive to CFTR function, as cells with reduced or absent CFTR function have decreased HDAC2 protein, resulting in hyperacetylation of the IL8 promoter and increased IL8 transcription. Reduced HDAC2 and HDAC2 activity, but not HDAC2 mRNA, is observed in cells deficient in CFTR. Suppressing HDAC2 expression with HDAC2 short hairpin RNA (shRNA) results in increased IL8 expression and promoter acetylation comparable with CFTR-deficient cells. Treating CFTR-deficient cells with N-acetyl-cysteine (NAC) increases HDAC2 expression to near control levels. Our data suggest that there is an intrinsic alteration in the HAT/HDAC balance in cells lacking CFTR function in vitro and in native CF tissue and that oxidative stress is likely contributing to this alteration. This mechanism, found in other inflammatory airway diseases, provides an explanation for the apparent dysregulation of inflammatory mediators seen in the CF airway, as reduced histone deacetylation would potentially influence many genes.

[1]  A. Clément,et al.  Cystic fibrosis transmembrane conductance regulator controls lung proteasomal degradation and nuclear factor-kappaB activity in conditions of oxidative stress. , 2008, The American journal of pathology.

[2]  W. MacNee,et al.  The effect of smoking on the transcriptional regulation of lung inflammation in patients with chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.

[3]  I. Adcock,et al.  Oxidative stress and redox regulation of lung inflammation in COPD , 2006, European Respiratory Journal.

[4]  I. Adcock,et al.  Epigenetics and airways disease , 2006, Respiratory research.

[5]  S. Choudhary,et al.  Respiratory Syncytial Virus-Inducible BCL-3 Expression Antagonizes the STAT/IRF and NF-κB Signaling Pathways by Inducing Histone Deacetylase 1 Recruitment to the Interleukin-8 Promoter , 2005, Journal of Virology.

[6]  I. Adcock,et al.  Decreased histone deacetylase activity in chronic obstructive pulmonary disease. , 2005, The New England journal of medicine.

[7]  D. Look,et al.  NF-kappaB activation and sustained IL-8 gene expression in primary cultures of cystic fibrosis airway epithelial cells stimulated with Pseudomonas aeruginosa. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[8]  S. L. Hyatt,et al.  Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution. , 2004, Human gene therapy.

[9]  Weihua Xiao Advances in NF-kappaB signaling transduction and transcription. , 2004, Cellular & molecular immunology.

[10]  I. Rahman,et al.  Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF‐κB activation and proinflammatory cytokine release in alveolar epithelial cells , 2004 .

[11]  I. Adcock,et al.  Theophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD Macrophages , 2004, The Journal of experimental medicine.

[12]  B. Day,et al.  Role for Cystic Fibrosis Transmembrane Conductance Regulator Protein in a Glutathione Response to Bronchopulmonary Pseudomonas Infection , 2004, Infection and Immunity.

[13]  I. Adcock,et al.  Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase , 2004, The Lancet.

[14]  I. Adcock,et al.  Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. , 2004, Biochemical and biophysical research communications.

[15]  Ping Zhu,et al.  The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2 , 2003, The EMBO journal.

[16]  W. MacNee,et al.  Histone acetylation regulates epithelial IL-8 release mediated by oxidative stress from environmental particles. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[17]  I. Adcock,et al.  The effect of oxidative stress on histone acetylation and IL-8 release. , 2003, Biochemical and biophysical research communications.

[18]  I. Rahman Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases. , 2003, Journal of biochemistry and molecular biology.

[19]  I. Adcock,et al.  Expression and activity of histone deacetylases in human asthmatic airways. , 2002, American journal of respiratory and critical care medicine.

[20]  I. Adcock,et al.  A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. O’Carroll,et al.  Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression , 2002, The EMBO journal.

[22]  W. MacNee,et al.  Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation. , 2002, Molecular and cellular biochemistry.

[23]  C. Peterson HDAC's at work: everyone doing their part. , 2002, Molecular cell.

[24]  M. Berger Lung inflammation early in cystic fibrosis: bugs are indicted, but the defense is guilty. , 2002, American journal of respiratory and critical care medicine.

[25]  Sandy D. Westerheide,et al.  The p65 (RelA) Subunit of NF-κB Interacts with the Histone Deacetylase (HDAC) Corepressors HDAC1 and HDAC2 To Negatively Regulate Gene Expression , 2001, Molecular and Cellular Biology.

[26]  C. Hubeau,et al.  Distinct pattern of immune cell population in the lung of human fetuses with cystic fibrosis. , 2001, The Journal of allergy and clinical immunology.

[27]  R. Bryan,et al.  Activation of NF-kappaB in airway epithelial cells is dependent on CFTR trafficking and Cl- channel function. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[28]  G. Mizuguchi,et al.  ATP-dependent Nucleosome Remodeling and Histone Hyperacetylation Synergistically Facilitate Transcription of Chromatin* , 2001, The Journal of Biological Chemistry.

[29]  I. Adcock,et al.  Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  P. Davis,et al.  Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[31]  J. Christman,et al.  Exaggerated Activation of Nuclear Factor- κ B and Altered I κ B- β Processing in Cystic Fibrosis Bronchial Epithelial Cells , 2000 .

[32]  S. de Bentzmann,et al.  Inflammation and infection in naive human cystic fibrosis airway grafts. , 2000, American journal of respiratory cell and molecular biology.

[33]  R. Eisenman,et al.  Sin Meets NuRD and Other Tails of Repression , 1999, Cell.

[34]  C. Glass,et al.  Transcriptional Activation by NF-κB Requires Multiple Coactivators , 1999, Molecular and Cellular Biology.

[35]  K. Roebuck Regulation of interleukin-8 gene expression. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[36]  Hueng-Sik Choi,et al.  Steroid Receptor Coactivator-1 Interacts with the p50 Subunit and Coactivates Nuclear Factor κB-mediated Transactivations* , 1998, The Journal of Biological Chemistry.

[37]  S. Ghosh,et al.  Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. , 1998, Molecular cell.

[38]  J. Carlin,et al.  Lower airway inflammation in infants and young children with cystic fibrosis. , 1997, American journal of respiratory and critical care medicine.

[39]  J. Hull,et al.  Pulmonary oxidative stress response in young children with cystic fibrosis. , 1997, Thorax.

[40]  M. Gerritsen,et al.  CREB-binding protein/p300 are transcriptional coactivators of p65. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[41]  D. Porteous,et al.  Early alterations in airway mucociliary clearance and inflammation of the lamina propria in CF mice. , 1997, The American journal of physiology.

[42]  T. Noah,et al.  Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. , 1997, The Journal of infectious diseases.

[43]  G. Nabel,et al.  Regulation of NF-κB by Cyclin-Dependent Kinases Associated with the p300 Coactivator , 1997, Science.

[44]  P. Davis,et al.  Overexpression of R domain eliminates cAMP-stimulated Cl- secretion in 9/HTEo- cells in culture. , 1996, The American journal of physiology.

[45]  J. Price,et al.  Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress. , 1996, The European respiratory journal.

[46]  M. Konstan,et al.  Inflammatory cytokines in cystic fibrosis lungs. , 1995, American journal of respiratory and critical care medicine.

[47]  P. Phelan,et al.  Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis , 1995, BMJ.

[48]  D. Riches,et al.  Early pulmonary inflammation in infants with cystic fibrosis. , 1995, American journal of respiratory and critical care medicine.

[49]  J. Lunec,et al.  Oxidative damage to DNA in patients with cystic fibrosis. , 1995, Free radical biology & medicine.

[50]  F. Kelly,et al.  Evidence for Increased oxidative Damage in Patients with Cystic Fibrosis , 1994, Pediatric Research.

[51]  M. F. Shannon,et al.  Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6. , 1994, Journal of immunology.

[52]  R. Crystal,et al.  Systemic deficiency of glutathione in cystic fibrosis. , 1993, Journal of applied physiology.

[53]  C. Rosen,et al.  NF-kappa B subunit-specific regulation of the interleukin-8 promoter , 1993, Molecular and cellular biology.

[54]  J. Warner,et al.  Interleukin-8 Concentrations Are Elevated in Bronchoalveolar Lavage, Sputum, and Sera of Children with Cystic Fibrosis , 1993, Pediatric Research.

[55]  M. Drumm,et al.  Oxidative stress causes IL8 promoter hyperacetylation in cystic fibrosis airway cell models. , 2009, American journal of respiratory cell and molecular biology.

[56]  I. Rahman,et al.  Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-kappaB activation and proinflammatory cytokine release in alveolar epithelial cells. , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[57]  S. Saccani,et al.  p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. , 2002, Nature immunology.

[58]  S. Saccani,et al.  p38-dependent marking of inflammatory genes for increased NF-κB recruitment , 2002, Nature Immunology.

[59]  J. Christman,et al.  Exaggerated activation of nuclear factor-kappaB and altered IkappaB-beta processing in cystic fibrosis bronchial epithelial cells. , 2000, American journal of respiratory cell and molecular biology.

[60]  T. Noah,et al.  Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. , 1999, American journal of respiratory and critical care medicine.

[61]  C. Glass,et al.  Transcriptional activation by NF-kappaB requires multiple coactivators. , 1999, Molecular and cellular biology.